Internal Medicine, Cardiovascular Disease · Glenside, PA
NPI
1255399366
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
805 E Willow Grove Ave, Ste C11
Glenside, PA, 19038
Phone (215) 966-1546
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,083 services
Medicare patients, 2024
110
Average age 73
Drug cost, 2024
$843K
6,350 prescriptions
Company payments, 2025
$1,188
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael W Milbourne was code 99214 (office e&m - established), 337 times for 105 patients. In total Michael W Milbourne billed 1,083 services in 30 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 337 | 105 | $97.97 | $33K |
| 93922 Duplex Scan - Extremity Arteries | Office | 66 | 53 | $60.93 | $4,021 |
| 93306 Echocardiography (TTE/TEE) | Office | 65 | 59 | $149.86 | $9,741 |
| 95921 Electrical Nerve Conductivity | Office | 64 | 49 | $68.03 | $4,354 |
| 99458 E&M - Miscellaneous | Office | 58 | 20 | $31.54 | $1,829 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 56 | 18 | $37.99 | $2,127 |
| 95923 Electrical Nerve Conductivity | Office | 55 | 44 | $92.53 | $5,089 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 51 | 51 | $168.90 | $8,614 |
| 93923 Duplex Scan - Extremity Arteries | Office | 46 | 34 | $107.02 | $4,923 |
| 93701 Cardiography | Office | 42 | 33 | $20.34 | $854 |
| 99457 E&M - Miscellaneous | Office | 41 | 23 | $38.76 | $1,589 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 37 | 18 | $51.14 | $1,892 |
| 99454 E&M - Miscellaneous | Office | 31 | 16 | $39.05 | $1,211 |
| 95250 Test - Miscellaneous | Office | 25 | 19 | $120.76 | $3,019 |
| 99453 E&M - Miscellaneous | Office | 18 | 16 | $14.06 | $253 |
By year: 2022 $99K for 1,028 services; 2023 $112K for 1,143 services; 2024 $99K for 1,083 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael W Milbourne prescribed most often to Medicare patients was Atorvastatin Calcium, with 425 prescriptions and refills. In total Michael W Milbourne wrote 6,350 Medicare prescriptions that cost $843K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 425 | 1,160 | 126 | $8,249 |
| Amlodipine Besylate Generic | 399 | 1,073 | 113 | $3,757 |
| Metoprolol Succinate Generic | 250 | 653 | 68 | $4,620 |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 179 | 517 | 59 | $14K |
| Entresto Sacubitril/Valsartan | 145 | 289 | 37 | $187K |
| Tamsulosin Hcl Generic | 140 | 332 | 40 | $1,887 |
| Rosuvastatin Calcium Generic | 139 | 402 | 44 | $3,811 |
| Hydralazine Hcl Generic | 136 | 307 | 34 | $1,382 |
| Hydrochlorothiazide Generic | 133 | 351 | 37 | $922 |
| Montelukast Sodium Generic | 124 | 242 | 29 | $1,528 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 122 | 156 | 28 | $3,467 |
| Carvedilol Generic | 118 | 318 | 38 | $1,418 |
| Metformin Hcl Generic | 111 | 263 | 31 | $992 |
| Furosemide Generic | 101 | 198 | 29 | $411 |
| Valsartan Generic | 98 | 282 | 29 | $4,642 |
Brand drugs: 952 claims; generic drugs: 5,334 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael W Milbourne $1,188 ($1,188 in general payments such as food, travel and fees) from 13 companies. The largest payer was Lilly USA, LLC with $208.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 5 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $207 |
| Amgen Inc. AMGN | 15 | $158 |
| Novo Nordisk Inc NVO | 5 | $123 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $104 |
| Merck Sharp & Dohme LLC MRK | 5 | $95.65 |
| Pfizer Inc. PFE | 4 | $86.38 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $72.5 |
| AGEPHA Pharma FZ LLC | 3 | $64.12 |
| Exact Sciences Corporation EXAS | 1 | $21.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.